
Daanyaal
CEO & Co-Founder
Background in investment banking at Investec Bank plc and FIS, with experience in strategic leadership, executive stakeholder management and analytical work across complex, time-critical transactions.
We speak with the clinicians, payers and patients closest to treatment decisions, then translate that evidence into practical direction for strategy, development and growth.
Sentio Research is a specialist pharmaceutical market research partner. We design and deliver primary research, secondary analysis and evidence synthesis for pharmaceutical, biotechnology, medtech and healthcare organisations.
Every engagement begins with the decision that needs to be made. We identify the evidence required, reach the relevant stakeholders and interpret what we learn in the context of treatment pathways, market access and commercial reality.
The result is research that does more than describe the market. It gives teams a stronger basis for deciding where to invest, how to position an asset and what to do next.
From focused stakeholder research to broader commercial assessments, each engagement is designed around a defined business or development question.
Specialist markets where access, pathways and adoption dynamics matter most.
Illustrative engagement
A biotechnology company developing a peptide-based asset intended to preserve or increase muscle mass during GLP-1-associated weight loss needed early commercial clarity before heavier investment in clinical and partnering plans.
We start from the commercial or development question you need to answer, not a generic research checklist.
Research-participant recruitment and fieldwork bring you to the clinicians, payers and patients who shape outcomes.
Findings are synthesised into implications for positioning, evidence, access and opportunity.
Deliverables are built for decision forums: what to do next, what to prove, and what risk remains.
The Sentio Research team combines experience in qualitative healthcare research, pharmaceutical commercial practice, medical advisory work and executive decision-making.

CEO & Co-Founder
Background in investment banking at Investec Bank plc and FIS, with experience in strategic leadership, executive stakeholder management and analytical work across complex, time-critical transactions.

Head of Research
Qualitative healthcare researcher specialising in neurology, oncology and rare diseases. Designs and delivers research programmes focused on patient, HCP and payer perspectives.

Head of Sales
Pharmaceutical commercial experience at Eli Lilly and Company, working with prescribing consultants across dermatology and rheumatology. Brings frontline insight into HCP engagement and treatment decision-making.

Head of Medical & Advisory
Qualified medical doctor and former Boston Consulting Group consultant, with additional life sciences advisory experience at Princeton Biopartners.
We recognise that healthcare market research requires more than strong methodology. It also requires careful governance, transparent participant processes, appropriate data handling and clear procedures for pharmacovigilance and confidentiality.
Research activities are designed with reference to UK GDPR and the Data Protection Act 2018, including appropriate participant information, lawful processing, controlled access, retention and deletion procedures.
Our research approach is informed by the BHBIA Legal and Ethical Guidelines for Healthcare Market Research, including participant transparency, confidentiality, appropriate incentives and separation of research from promotion.
Share your contact details and the commercial or development question you are facing. We will come back with a view on approach, markets and timing.
Our operating framework is being developed with reference to applicable market-research, data-protection and pharmaceutical industry guidance. Project-specific requirements are agreed before fieldwork begins.